These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15100599)

  • 1. Levetiracetam as migraine prophylaxis.
    Cochran JW
    Clin J Pain; 2004; 20(3):198-9. PubMed ID: 15100599
    [No Abstract]   [Full Text] [Related]  

  • 2. Levetiracetam prophylaxis in pediatric migraine--an open-label study.
    Pakalnis A; Kring D; Meier L
    Headache; 2007 Mar; 47(3):427-30. PubMed ID: 17371359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elderly patients with migraine: an open-label study on prophylaxis therapy with levetiracetam.
    Pizza V; Busillo V; Agresta A; Bisogno A; Capasso A
    Cent Nerv Syst Agents Med Chem; 2011 Mar; 11(1):31-4. PubMed ID: 21250937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of levetiracetam in pediatric migraine.
    Miller GS
    Headache; 2004 Mar; 44(3):238-43. PubMed ID: 15012661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
    Kashipazha D; Ghadikolaei HS; Siavashi M
    Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of levetiracetam for migraine prophylaxis: A systematic review.
    Watkins AK; Gee ME; Brown JN
    J Clin Pharm Ther; 2018 Aug; 43(4):467-475. PubMed ID: 29781197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in L-dopa-induced dyskinesia.
    Meco G; Fabrizio E; Epifanio A; Di Raimondo G; Vanacore N; Morgante L
    Clin Neuropharmacol; 2005; 28(2):102-3. PubMed ID: 15795556
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiepileptic drugs in migraine prophylaxis: state of the art.
    Capuano A; Vollono C; Mei D; Pierguidi L; Ferraro D; Di Trapani G
    Clin Ter; 2004; 155(2-3):79-87. PubMed ID: 15244112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study.
    Brighina F; Palermo A; Aloisio A; Francolini M; Giglia G; Fierro B
    Clin Neuropharmacol; 2006; 29(6):338-42. PubMed ID: 17095897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin or levetiracetam for seizure prophylaxis in TBI.
    DeDea L
    JAAPA; 2012 Dec; 25(12):11. PubMed ID: 23599996
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of amiodarone-associated myoclonus responsive to levetiracetam.
    Deik AF; Shanker VL
    Can J Neurol Sci; 2012 Sep; 39(5):680-1. PubMed ID: 23066555
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term continuation of levetiracetam in patients with refractory epilepsy.
    Krakow K; Walker M; Otoul C; Sander JW
    Neurology; 2001 Jun; 56(12):1772-4. PubMed ID: 11425954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam in the treatment of idiopathic hemifacial spasm.
    Deleu D
    Neurology; 2004 Jun; 62(11):2134-5. PubMed ID: 15184638
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.
    Karamchandani RR; Fletcher JJ; Pandey AS; Rajajee V
    J Clin Neurosci; 2014 Sep; 21(9):1507-13. PubMed ID: 24919470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of spinal myoclonus with levetiracetam.
    Keswani SC; Kossoff EH; Krauss GL; Hagerty C
    J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):457-8. PubMed ID: 12235322
    [No Abstract]   [Full Text] [Related]  

  • 16. The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.
    Holbech JV; Otto M; Bach FW; Jensen TS; Sindrup SH
    Eur J Pain; 2011 Jul; 15(6):608-14. PubMed ID: 21183370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tolerability and efficacy of levetiracetam.
    Tellez-Zenteno JF
    Can J Neurol Sci; 2010 May; 37(3):309. PubMed ID: 20481263
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiepileptic drugs for the prevention of pediatric migraine].
    Cuvellier JC
    Rev Neurol (Paris); 2009 Dec; 165(12):1002-9. PubMed ID: 19345966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of early diagnosed post-anoxic myoclonus with levetiracetam.
    Venot M; Weiss N; Espinoza S; Imbert A; Tadie JM; Fagon JY; Guerot E; Diehl JL
    Intensive Care Med; 2011 Jan; 37(1):177-9. PubMed ID: 20871977
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of levetiracetam in refractory status epilepticus.
    Patel NC; Landan IR; Levin J; Szaflarski J; Wilner AN
    Seizure; 2006 Apr; 15(3):137-41. PubMed ID: 16426869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.